
Company Info
Year Established2007
Ticker
CLYY
Exchange
OTCMKTS
Contacts
Michel LussierInterim CEO
Eytan Breman
Director, R&D
Company Description
Celyad Oncology is a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of revolutionary technologies for chimeric antigen receptor (CAR) T-cells.